Effect of Sevelamer on Calciprotein Particles in Hemodialysis Patients: The Sevelamer Versus Calcium to Reduce Fetuin-A-Containing Calciprotein Particles in Dialysis (SCaRF) Randomized Controlled Trial
Edward R Smith, Fei Fei M Pan, Tim D Hewitson, Nigel D Toussaint, Stephen G Holt
Kidney International Reports | ELSEVIER SCIENCE INC | Published : 2020
Study funding and investigational drug was kindly provided by Sanofi-Aventis (Singapore) Pte Ltd. The investigators are solely responsible for the design, conduct, collection, analysis, and interpretation of the data, writing of the report, and the decision to submit for publication, with no input from Sanofi-Aventis (Singapore) Pte Ltd.